Alzheimer’s Society funds high-quality research across all areas of dementia that are most relevant to people affected by the ...

Research studies offer hope that we can one day end the devastation caused by dementia – and research is only possible thanks ...

A major clinical trial aiming to transform the diagnosis of Alzheimer’s disease through a simple blood test, is now welcoming its first participants who will be recruited via memory clinics across the ...

Turning Up the Volume is the largest-ever survey with people with dementia to hear their views and experiences of what daily life is like. Turning Up the Volume: unheard voices of people with dementia ...

Alzheimer’s Society is continuing work on the Blood Biomarker Challenge, a project that could bring dementia blood tests to the NHS within five years. Blood-based biomarkers could be the ...

In August 2024, lecanemab (marketed as Leqembi in the UK) was approved as a treatment for some people living with early Alzheimer’s disease. The drug can slow down the decline in memory and thinking ...

Children and young people can help the person with dementia. While it won't always be appropriate for them to be involved, there are aspects of caring that are fulfilling. Explaining dementia to ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved donanemab (marketed as Kisunla in the UK) as a treatment for some people with early-stage Alzheimer’s disease. The drug can ...

Finding out that someone close to you has dementia is difficult. Children and young people, who may not fully understand what dementia is or how to cope with their emotions, may need extra support.

Val Horncastle, who had Alzheimer’s disease, came up with the idea for the ‘Memory Calendar’ with her husband Keith. We hear how a calendar designed to help one person is benefiting many others. Val ...

Helpcards are for people with dementia or memory problems. They can make it easier for the person to get support when they’re out in the community. Helpcards are a free tool for people who have memory ...

Dr Richard Oakley, Associate Director of Research at Alzheimer’s Society, has called breakthrough Alzheimer's drug donanemab, 'a turning point', as the full trial results were revealed. Full results ...